Literature DB >> 22275539

Angiotensin II infusion model of hypertension: is there an important sympathetic component?

Thomas E Lohmeier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22275539      PMCID： PMC3839631          DOI： 10.1161/HYPERTENSIONAHA.111.188714

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  13 in total

1.  What sets the long-term level of renal sympathetic nerve activity: a role for angiotensin II and baroreflexes?

Authors:  Carolyn J Barrett; Rohit Ramchandra; Sarah-Jane Guild; Aneela Lala; David M Budgett; Simon C Malpas
Journal:  Circ Res       Date:  2003-05-22       Impact factor: 17.367

2.  Influence of prolonged baroreflex activation on arterial pressure in angiotensin hypertension.

Authors:  Thomas E Lohmeier; Terry M Dwyer; Drew A Hildebrandt; Eric D Irwin; Martin A Rossing; David J Serdar; Robert S Kieval
Journal:  Hypertension       Date:  2005-10-10       Impact factor: 10.190

3.  Baroreceptor denervation prevents sympathoinhibition during angiotensin II-induced hypertension.

Authors:  Carolyn J Barrett; Sarah-Jane Guild; Rohit Ramchandra; Simon C Malpas
Journal:  Hypertension       Date:  2005-05-23       Impact factor: 10.190

4.  Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.

Authors:  Murray D Esler; Henry Krum; Paul A Sobotka; Markus P Schlaich; Roland E Schmieder; Michael Böhm
Journal:  Lancet       Date:  2010-11-17       Impact factor: 79.321

Review 5.  Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions.

Authors:  M Esler; G Jennings; G Lambert; I Meredith; M Horne; G Eisenhofer
Journal:  Physiol Rev       Date:  1990-10       Impact factor: 37.312

6.  Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial.

Authors:  John D Bisognano; George Bakris; Mitra K Nadim; Luis Sanchez; Abraham A Kroon; Jill Schafer; Peter W de Leeuw; Domenic A Sica
Journal:  J Am Coll Cardiol       Date:  2011-08-09       Impact factor: 24.094

7.  Chronic angiotensin II infusion decreases renal norepinephrine overflow in conscious dogs.

Authors:  R G Carroll; T E Lohmeier; A J Brown
Journal:  Hypertension       Date:  1984 Sep-Oct       Impact factor: 10.190

8.  Quantification of baroreceptor influence on arterial pressure changes seen in primary angiotension-induced hypertension in dogs.

Authors:  A W Cowley; J W DeClue
Journal:  Circ Res       Date:  1976-12       Impact factor: 17.367

9.  Angiotensin II-based hypertension and the sympathetic nervous system: the role of dose and increased dietary salt in rabbits.

Authors:  Fiona D McBryde; Sarah-Jane Guild; Carolyn J Barrett; John W Osborn; Simon C Malpas
Journal:  Exp Physiol       Date:  2007-04-27       Impact factor: 2.969

10.  Chronic angiotensin II infusion causes differential responses in regional sympathetic nerve activity in rats.

Authors:  Misa Yoshimoto; Kenju Miki; Gregory D Fink; Andrew King; John W Osborn
Journal:  Hypertension       Date:  2010-01-25       Impact factor: 10.190
View more
  7 in total

Review 1.  The renin-angiotensin system in cardiovascular autonomic control: recent developments and clinical implications.

Authors:  Amanda J Miller; Amy C Arnold
Journal:  Clin Auton Res       Date:  2018-11-09       Impact factor: 4.435

2.  Evidence against a crucial role of renal medullary perfusion in blood pressure control of hypertensive rats.

Authors:  Bożena Bądzyńska; Iwona Baranowska; Olga Gawryś; Janusz Sadowski
Journal:  J Physiol       Date:  2018-11-10       Impact factor: 5.182

3.  Central angiotensin II-Protein inhibitor of neuronal nitric oxide synthase (PIN) axis contribute to neurogenic hypertension.

Authors:  Neeru M Sharma; Andrea S Haibara; Kenichi Katsurada; Xuefei Liu; Kaushik P Patel
Journal:  Nitric Oxide       Date:  2019-10-22       Impact factor: 4.427

4.  Hypertension and Pathogenic hAPP Independently Induce White Matter Astrocytosis and Cognitive Impairment in the Rat.

Authors:  Alexander Levit; Sonny Cheng; Olivia Hough; Qingfan Liu; Yuksel Agca; Cansu Agca; Vladimir Hachinski; Shawn N Whitehead
Journal:  Front Aging Neurosci       Date:  2020-04-15       Impact factor: 5.750

5.  Systemic administration of choline acetyltransferase decreases blood pressure in murine hypertension.

Authors:  Andrew Stiegler; Jian-Hua Li; Vivek Shah; Tea Tsaava; Aisling Tynan; Huan Yang; Yehuda Tamari; Michael Brines; Kevin J Tracey; Sangeeta S Chavan
Journal:  Mol Med       Date:  2021-10-21       Impact factor: 6.354

6.  Angiotensin II-induced Hypertension is Reduced by Deficiency of P-selectin Glycoprotein Ligand-1.

Authors:  Qian Wang; Hui Wang; Jintao Wang; Jessica Venugopal; Kyle Kleiman; Chiao Guo; Yingxian Sun; Daniel T Eitzman
Journal:  Sci Rep       Date:  2018-02-19       Impact factor: 4.379

7.  Role of a RhoA/ROCK-Dependent Pathway on Renal Connexin43 Regulation in the Angiotensin II-Induced Renal Damage.

Authors:  Gonzalo I Gómez; Victoria Velarde; Juan C Sáez
Journal:  Int J Mol Sci       Date:  2019-09-07       Impact factor: 5.923
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.